RESMED INC
RMDAPI behind this page
RMD Q4 2025 request
Playground key active
/api/financials?ticker=RMD&year=2025&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue | 1,347,993 | 1,223,195 | +10.2% |
Show Product Lines breakouts |
|||
| Residential Care Software | 167,008 | 151,938 | +9.9% |
| Sleep and Breathing Health | 1,180,985 | 1,071,257 | +10.2% |
Show Business Segments breakouts |
|||
| Residential Care Software | 167,008 | 151,938 | +9.9% |
| Sleep and Breathing Health | 1,180,985 | 1,071,257 | +10.2% |
Show — breakouts |
|||
| Revenue | 2,535,935 | 2,287,642 | +10.9% |
| Revenue | 389,043 | 343,861 | +13.1% |
| Revenue | -107,573 | -113,502 | +5.2% |
| Revenue | -621,717 | -577,392 | -7.7% |
| Revenue | -110,543 | -103,680 | -6.6% |
| Revenue | -800,820 | -739,546 | -8.3% |
| Revenue | -2,143,921 | -1,939,344 | -10.5% |
| Revenue | -2,455,233 | -2,262,304 | -8.5% |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 518,557 | 499,681 | +3.8% |
Show Product Lines breakouts |
|||
| Residential Care Software | 48,516 | 46,451 | +4.4% |
| Sleep and Breathing Health | 470,041 | 453,230 | +3.7% |
| Amortization Of Intangible Assets | 9,368 | 7,987 | +17.3% |
Show Product Lines breakouts |
|||
| Residential Care Software | 6,344 | 6,766 | -6.2% |
| Sleep and Breathing Health | 3,024 | 1,221 | +147.7% |
| Cost of Revenue | 527,925 | 507,668 | +4.0% |
| Gross Profit | 820,068 | 715,527 | +14.6% |
| Selling, General & Administrative | 265,125 | 242,188 | +9.5% |
| Research & Development | 86,444 | 80,861 | +6.9% |
| Amortization Of Acquired Intangible Assets1 | 11,928 | 11,262 | +5.9% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 21,296 | 19,249 | +10.6% |
| Operating Expenses | 365,528 | 334,311 | +9.3% |
| Operating Income | 454,540 | 381,216 | +19.2% |
Show Business Segments breakouts |
|||
| Residential Care Software · Operating Segments | 55,318 | 42,604 | +29.8% |
| Sleep and Breathing Health · Operating Segments | 519,893 | 441,293 | +17.8% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 575,211 | 483,897 | +18.9% |
| Interest Income Expense Nonoperating Net | 5,757 | -5,921 | +197.2% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -5,757 | 5,921 | -197.2% |
| Income Loss From Equity Method Investments | 1,269 | 868 | +46.2% |
Show Financial Instrument breakouts |
|||
| Equity Method Investments | 1,269 | 868 | +46.2% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -6,019 | 4,564 | -231.9% |
| Equity Securities Fv Ni Gain Loss | -2,534 | -15,474 | +83.6% |
| Other Non-Operating Income (Expense) | -979 | -2,957 | +66.9% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 979 | 2,957 | -66.9% |
| Non-Operating Income (Expense) | 3,513 | -23,484 | +115.0% |
| Income Before Taxes | 458,053 | 357,732 | +28.0% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 458,053 | 357,732 | +28.0% |
| Income Tax Expense (Benefit) | 78,348 | 65,496 | +19.6% |
| Net Income | 379,705 | 292,236 | +29.9% |
| EPS (Basic) | 2.59 | 1.98 | +30.8% |
| EPS (Diluted) | 2.58 | 1.98 | +30.3% |
| Common Stock Dividends Per Share Declared | 0.53 | 0.48 | +10.4% |
| Wtd Avg Shares (Basic) | -81 | -35 | -131.4% |
| Wtd Avg Shares (Diluted) | -92 | 1 | -9300.0% |
| Comprehensive Income | 555,862 | 306,013 | +81.6% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,209,450 | 238,361 | +407.4% |
Show Cash And Cash Equivalents breakouts |
|||
| High Yield Cash and Cash Equivalent | 302.7 | — | — |
| Accounts Receivable | 939,492 | 837,275 | +12.2% |
Show Balance Sheet Location breakouts |
|||
| Accounts receivable, net | 939,492 | 837,275 | +12.2% |
| Inventory | 927,711 | 822,250 | +12.8% |
| Prepaid Expenses & Other Current Assets | 428,952 | 459,833 | -6.7% |
| Total Current Assets | 3,505,605 | 2,357,719 | +48.7% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 550,790 | 548,025 | +0.5% |
| Operating Lease Right-of-Use Assets | 167,497 | 151,121 | +10.8% |
| Goodwill | 3,046,680 | 2,842,055 | +7.2% |
Show Business Segments breakouts |
|||
| Residential Care Software | 2,163,102 | 2,084,526 | +3.8% |
| Sleep and Breathing Health | 883,578 | 757,529 | +16.6% |
| Intangible Assets | 464,861 | 485,904 | -4.3% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 286,491 | 281,984 | +1.6% |
| Developed/core product technology | 81,210 | 103,709 | -21.7% |
| Other Intangible Assets | 97,160 | 100,211 | -3.0% |
| Deferred Income Taxes And Other Assets Noncurrent | 253,119 | 203,569 | +24.3% |
| Other Non-Current Assets | 185,839 | 284,001 | -34.6% |
| Assets Noncurrent | 4,668,786 | 4,514,675 | +3.4% |
| Total Assets | 8,174,391 | 6,872,394 | +18.9% |
| Current Liabilities | |||
| Accounts Payable | 278,157 | 237,728 | +17.0% |
| Accrued Liabilities | 402,253 | 377,678 | +6.5% |
| Operating Lease Liability Current | 30,506 | 25,278 | +20.7% |
| Deferred Revenue (Current) | 166,030 | 152,554 | +8.8% |
Show Balance Sheet Location breakouts |
|||
| Deferred revenue (current liabilities) | 166,030 | 152,554 | +8.8% |
| Accrued Income Taxes Current | 132,274 | 107,517 | +23.0% |
| Short Term Borrowings | 9,900 | 9,900 | 0.0% |
| Total Current Liabilities | 1,019,120 | 910,655 | +11.9% |
| Non-Current Liabilities | |||
| Contract With Customer Liability Noncurrent | 156,803 | 137,343 | +14.2% |
Show Balance Sheet Location breakouts |
|||
| Deferred revenue (non-current liabilities) | 156,803 | 137,343 | +14.2% |
| Deferred Income Taxes And Other Tax Liabilities Noncurrent | 77,682 | 79,339 | -2.1% |
| Operating Lease Liabilities | 153,015 | 141,444 | +8.2% |
| Other Non-Current Liabilities | 141,520 | 42,257 | +234.9% |
| Long-Term Debt | 658,392 | 697,313 | -5.6% |
| Liabilities Noncurrent | 1,187,412 | 1,097,696 | +8.2% |
| Total Liabilities | 2,206,532 | 2,008,351 | +9.9% |
| Stockholders' Equity | |||
| Common Stock Value Outstanding | 761 | 588 | +29.4% |
| Additional Paid In Capital Common Stock | 2,033,599 | 1,896,604 | +7.2% |
| Retained Earnings | 6,081,490 | 4,991,647 | +21.8% |
| Treasury Stock Common Value | -2,073,292 | -1,773,267 | -16.9% |
| Accumulated Other Comprehensive Income | -74,699 | -251,529 | +70.3% |
| Total Stockholders' Equity | 5,967,859 | 4,864,043 | +22.7% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -74,699 | -251,529 | +70.3% |
| Additional Paid In Capital | 2,033,599 | 1,896,604 | +7.2% |
| Common Stock | 761 | 588 | +29.4% |
| Retained Earnings | 6,081,490 | 4,991,647 | +21.8% |
| Treasury Stock Common | -2,073,292 | -1,773,267 | -16.9% |
| Total Liabilities & Equity | 8,174,391 | 6,872,394 | +18.9% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 63,628 | 43,678 | +45.7% |
Show Business Segments breakouts |
|||
| Residential Care Software · Operating Segments | 2,608 | 2,398 | +8.8% |
| Sleep and Breathing Health · Operating Segments | 39,456 | 21,763 | +81.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 21,564 | 19,517 | +10.5% |
| Operating Lease Right Of Use Asset Amortization Expense | 10,660 | 11,077 | -3.8% |
| Stock-Based Compensation | 24,751 | 21,392 | +15.7% |
| Debt And Equity Securities Unrealized Gain Loss | 2,534 | 15,474 | -83.6% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -18,064 | 7,384 | -344.6% |
| Change in Accounts Receivable | -5,215 | -57,523 | +90.9% |
| Change in Inventory | -32,133 | 8,909 | -460.7% |
| Change in Prepaid & Other Assets | 47,017 | -16,237 | +389.6% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 49,088 | 121,976 | -59.8% |
| Net Cash from Operations | 538,766 | 440,114 | +22.4% |
| Investing Activities | |||
| Capital Expenditures | -30,585 | -24,881 | -22.9% |
| Payments To Acquire Intangible Assets | -3,193 | -1,442 | -121.4% |
| Payments To Acquire Businesses Net Of Cash Acquired | -138,578 | -19,697 | -603.5% |
| Payments To Acquire Investments | -2,013 | -3,073 | +34.5% |
| Proceeds From Sale Maturity And Collections Of Investments | 250 | 750 | -66.7% |
| Payments For Proceeds From Derivative Instrument Investing Activities | 40,406 | 1,834 | +2103.2% |
| Net Cash from Investing | -133,713 | -46,509 | -187.5% |
| Financing Activities | |||
| Proceeds From Issuance Of Common Stock | 30,156 | 27,695 | +8.9% |
| Tax Withholding for Share Compensation | -590 | -421 | -40.1% |
| Share Repurchases | -100,008 | -50,004 | -100.0% |
| Payments Of Merger Related Costs Financing Activities | 0 | 0 | — |
| Repayments Of Long Term Debt | -5,000 | -300,000 | +98.3% |
| Payments Of Dividends | -77,590 | -70,553 | -10.0% |
| Net Cash from Financing | -163,887 | -393,283 | +58.3% |
| Supplemental | |||
| Income Taxes Paid | 16,178 | 43,155 | -62.5% |
| Interest Paid | 6,912 | 5,921 | +16.7% |
| Business Acquisition Contingent Consideration Recognized Liability | -670 | 0 | — |
| Payments To Acquire Businesses Gross | 138,578 | 19,697 | +603.5% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 35,573 | 129 | +27476.0% |
| Net Change in Cash | 276,739 | 451 | +61261.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,209,450 | 238,361 | +407.4% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.